Role of Galactosylceramide Metabolism in Satellite Glial Cell Dysfunction and Neuron–Glia Interactions in Painful Diabetic Peripheral Neuropathy
Cells · 2025
DOI: 10.3390/cells14060393 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Xin Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200011, China. Hauptthemen laut MEDLINE: Diabetic Neuropathies, Galactosylceramides, Neurons, Neuroglia. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality, Project of Biobank from Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine.
Abstract (Originalsprache)
Diabetic peripheral neuropathy (DPN) is a prevalent and disabling complication of diabetes, with painful diabetic peripheral neuropathy (PDPN) being its most severe subtype due to chronic pain and resistance to treatment. Satellite glial cells (SGCs), critical for maintaining dorsal root ganglion (DRG) homeostasis, undergo significant structural and functional changes under pathological conditions. This study investigated the role of galactosylceramide (GalCer), a key sphingolipid, in SGC dysfunction and neuron–glia interactions during DPN progression. Using a rat model of PDPN, we employed single-cell RNA sequencing (scRNA-seq), targeted mass spectrometry, and immunofluorescence analysis. The PDPN group exhibited transcriptional activation and structural reorganization of SGCs, characterized by increased SGC abundance and glial activation, evidenced by elevated Gfap expression. Functional enrichment analyses revealed disruptions in sphingolipid metabolism, including marked reductions in GalCer levels. Subclustering identified vulnerable SGC subsets, such as Cluster a, with dysregulated lipid metabolism. The depletion of GalCer impaired SGC-neuron communication, destabilizing DRG homeostasis and amplifying neurodegeneration and neuropathic pain. These findings demonstrate that GalCer depletion is a central mediator of SGC dysfunction in PDPN, disrupting neuron–glia interactions and exacerbating neuropathic pain. This study provides novel insights into the molecular mechanisms of DPN progression and identifies GalCer metabolism as a potential therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200011, China.
ORCID-Profile: Xin Xu, Chenlong Liao, Wenchuan Zhang
Förderung
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
- Project of Biobank from Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
- Young Scientists Fund
- Project of Biobank from Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine
Zitieren
APA
Xu, X., Zhang, Y., Li, S., Liao, C., Yang, X., & Zhang, W. (2025). Role of Galactosylceramide Metabolism in Satellite Glial Cell Dysfunction and Neuron–Glia Interactions in Painful Diabetic Peripheral Neuropathy. Cells. https://doi.org/10.3390/cells14060393
Vancouver
Xu X, Zhang Y, Li S, Liao C, Yang X, Zhang W. Role of Galactosylceramide Metabolism in Satellite Glial Cell Dysfunction and Neuron–Glia Interactions in Painful Diabetic Peripheral Neuropathy. Cells. 2025. doi:10.3390/cells14060393
BibTeX
@article{Xu2025,
author = {Xu, Xin and Zhang, Yue and Li, Shuo and Liao, Chenlong and Yang, Xiaosheng and Zhang, Wenchuan},
title = {Role of Galactosylceramide Metabolism in Satellite Glial Cell Dysfunction and Neuron–Glia Interactions in Painful Diabetic Peripheral Neuropathy},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14060393}
}
EUVIMED